Immune Response to H. Pylori Infection

对幽门螺杆菌感染的免疫反应

基本信息

  • 批准号:
    8320334
  • 负责人:
  • 金额:
    $ 28.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

The host immune response plays a critical role in determining disease manifestations of chronic infections. Inadequate immune response may fail to control infection, although in other cases the specific immune response may be the cause of tissue damage and disease. The majority of patients with chronic infections are likely to be infected by more than one organism; however, the interaction between multiple active infections is not known, nor is the impact on disease outcome clear. Chronic infections such as Helicobacter pylori are the cause of considerable morbidity and mortality, worldwide. Unlike acute infections, where the "one microbe- one disease" concept can be applied, disease caused by chronic infectious organisms more likely represents interactions between the infecting organism(s) and a multitude of hosts and environmental factors including interaction with other infectious agents [1]. We and others have demonstrated the high incidence of helminthiasis in select Colombian populations, particularly children (2,3]. Our preliminary studies [2] suggest that the immune response to H. pylori infection in the low-risk coastal population is predominantly type Th2 and that it may be related to intestinal helminthiasis. This observation is consistent with our report that intestinal helminthiasis reduced gastric atrophy, a premalignant lesion, in the C57BL/6 mouse model of Helicobacter gastritis [4]. Our recent studies in gerbils demonstrating an H. pylori-associated attenuation of premalignant lesions in gerbils coinfected with Brugia sp. also support this hypothesis. In these proposed studies, we will test the hypothesis that progression to gastric cancer is influenced not only by the genotype of H. pylori (i.e., the ability of H. pylori strains from patients in regions of high gastric cancer risk areas to cause more nitrosative and oxidative damage vs. H. pylori strains in low gastric cancer risk areas) [5], but also by concun-ent infection with parasites which can modulate systemic immune responses and the Th1/Th2 gastric cytokine profile. RELEVANCE (See Instructions): The host immune response is important in determining how an individual responds to the chronic infection in the stomach caused by Helicobacter pylori. These immune responses play a critical role in predicting why certain patients with H. pylori infection develop gastric cancer.
宿主免疫反应在确定慢性感染的疾病表现中起着至关重要的作用。 免疫反应不足可能无法控制感染,尽管在其他情况下,特异性免疫 反应可能是组织损伤和疾病的原因。大多数患者患有慢性感染 可能被不止一种生物体感染;然而,多个主动之间的相互作用 感染情况尚不清楚,对疾病结果的影响也不清楚。慢性感染,例如螺杆菌 幽门螺杆菌是世界范围内相当大的发病率和死亡率的原因。与急性感染不同, 可应用“一种微生物-一种疾病”概念,慢性传染性微生物引起的疾病更多 可能代表感染生物体与众多宿主和环境之间的相互作用 因素包括与其他传染源的相互作用[1]。 我们和其他人已经证明了哥伦比亚特定人群中蠕虫病的高发病率, 特别是儿童 (2,3]。我们的初步研究 [2] 表明对幽门螺杆菌感染的免疫反应 在低风险沿海人群中,Th2 型占主导地位,可能与肠道相关 蠕虫病。这一观察结果与我们的报告一致,即肠道蠕虫病减少了胃 萎缩是螺杆菌胃炎 C57BL/6 小鼠模型中的一种癌前病变 [4]。我们最近的研究 在沙鼠中显示出与幽门螺杆菌相关的恶变前病变的减弱 布鲁贾属sp。也支持这一假设。 在这些拟议的研究中,我们将检验以下假设:胃癌的进展不受影响 仅取决于幽门螺杆菌的基因型(即,来自高胃粘膜区域患者的幽门螺杆菌菌株的能力) 在低位胃癌中,与幽门螺杆菌菌株相比,癌症风险区域会造成更多的亚硝化和氧化损伤 危险区域)[5],但也通过同时感染可以调节全身免疫的寄生虫 反应和 Th1/Th2 胃细胞因子谱。 相关性(参见说明): 宿主免疫反应对于确定个体如何应对慢性感染非常重要。 胃病是由幽门螺杆菌引起的。这些免疫反应在预测原因方面发挥着关键作用 某些幽门螺杆菌感染患者会发展为胃癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES G FOX其他文献

JAMES G FOX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES G FOX', 18)}}的其他基金

Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
  • 批准号:
    10709135
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
Developing and Improving Institutional Animal Resources (G20)
开发和改善机构动物资源(G20)
  • 批准号:
    8901502
  • 财政年份:
    2015
  • 资助金额:
    $ 28.41万
  • 项目类别:
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in Mice
新兴肠肝螺杆菌的诊断和病理学。
  • 批准号:
    8484473
  • 财政年份:
    2011
  • 资助金额:
    $ 28.41万
  • 项目类别:
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in Mice
新兴肠肝螺杆菌的诊断和病理学。
  • 批准号:
    8308332
  • 财政年份:
    2011
  • 资助金额:
    $ 28.41万
  • 项目类别:
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in Mice
新兴肠肝螺杆菌的诊断和病理学。
  • 批准号:
    8676962
  • 财政年份:
    2011
  • 资助金额:
    $ 28.41万
  • 项目类别:
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in Mice
新兴肠肝螺杆菌的诊断和病理学。
  • 批准号:
    8137460
  • 财政年份:
    2011
  • 资助金额:
    $ 28.41万
  • 项目类别:
Extramural Research Facilities Improvement Program
校外研究设施改进计划
  • 批准号:
    7877590
  • 财政年份:
    2010
  • 资助金额:
    $ 28.41万
  • 项目类别:
Animal Resource and Pathology Core
动物资源和病理学核心
  • 批准号:
    7514465
  • 财政年份:
    2009
  • 资助金额:
    $ 28.41万
  • 项目类别:
Immune Response to H. Pylori Infection
对幽门螺杆菌感染的免疫反应
  • 批准号:
    7749282
  • 财政年份:
    2009
  • 资助金额:
    $ 28.41万
  • 项目类别:
HUS Pathogenesis & clinical Outcome in an in vivo model
溶血性尿毒症发病机制
  • 批准号:
    7502098
  • 财政年份:
    2007
  • 资助金额:
    $ 28.41万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了